Representation of Lumenis in its acquisition by XIO Group for approximately $510 million
Meitar represented Lumenis, a global leader in the field of minimally-invasive clinical solutions for the surgical, ophthalmology and aesthetic markets, in its acquisition by XIO Group, a Chinese private equity fund, for approximately $510 million.